文献速递消化内镜消化道肿瘤与早癌

内镜医师每次结肠镜检查的腺瘤检出率与结肠镜后结直肠癌风险:新罕布什尔结肠镜登记数据

Endoscopist adenomas-per-colonoscopy detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.
PubMed 文献 · Gastrointest Endosc · 2023-11-21

基于新罕布什尔结肠镜登记数据,纳入32535例有索引检查及至少1次随访事件的患者,按内镜医师特异性腺瘤检出率(APC)五分位分组,用Cox回归分析APC与结肠镜后结直肠癌(PCCRC)风险的关系。结果显示APC较高组PCCRC风险低于APC<0.25参考组,提示APC可能是有用的质量指标。

要点

  • APC≥0.70组PCCRC风险低于APC<0.25参考组(HR 0.19,95%CI 0.09-0.37)。
  • 腺瘤检出率(ADR)≥25%的内镜医师中,APC<0.50者PCCRC风险高于APC≥0.50者(HR 1.65,95%CI 1.06-2.56)。
  • 152名内镜医师中32名(21.1%)ADR≥25%但APC<0.50。

核心结论

  • APC较高的内镜医师所行检查的PCCRC风险较低,提示APC可能是有用的质量指标。
  • 质量改进项目可通过测量ADR≥25%内镜医师的APC来识别检测性能的重要缺陷。

研究设计与样本

  • 使用新罕布什尔结肠镜登记数据,纳入有索引检查及至少1次随访事件(结肠镜检查或结直肠癌诊断)的患者。
  • 共纳入32535例患者,PCCRC定义为索引检查后≥6个月诊断的任何结直肠癌。
  • 暴露变量为内镜医师特异性APC五分位:0.25、0.40、0.50和0.70。
  • 采用Cox回归分析APC与PCCRC风险,控制年龄、性别、索引检查年份、索引发现、肠道准备及是否超过1次监测检查。

主要发现

  • 32535例患者中发生PCCRC 178例。
  • 与APC<0.25参考组相比,APC 0.25至<0.40组HR 0.35(95%CI 0.22-0.56)。
  • 与APC<0.25参考组相比,APC 0.40至<0.50组HR 0.31(95%CI 0.20-0.49)。
  • 与APC<0.25参考组相比,APC 0.50至<0.70组HR 0.20(95%CI 0.11-0.36)。
  • 与APC<0.25参考组相比,APC≥0.70组HR 0.19(95%CI 0.09-0.37)。

关键数值与推荐

  • 内镜医师特异性APC五分位切点为0.25、0.40、0.50和0.70。
  • PCCRC定义为索引检查后≥6个月诊断的任何结直肠癌。
  • 152名内镜医师中32名(21.1%)ADR≥25%但APC<0.50。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Adenomas per colonoscopy (APC) may be a better measure of colonoscopy quality than adenoma detection rate (ADR) because it credits endoscopists for each detected adenoma. There are few data examining the association between APC and postcolonoscopy colorectal cancer (PCCRC) incidence. We used data from the New Hampshire Colonoscopy Registry to examine APC and PCCRC risk. METHODS: We included New Hampshire Colonoscopy Registry patients with an index examination and at least 1 follow-up event, either a colonoscopy or a colorectal cancer (CRC) diagnosis. Our outcome was PCCRC defined as any CRC diagnosed ≥6 months after an index examination. The exposure variable was endoscopist-specific APC quintiles of .25, .40, .50, and .70. Cox regression was used to model the hazard of PCCRC on APC, controlled for age, sex, year of index examination, index findings, bowel preparation, and having more than 1 surveillance examination. RESULTS: In 32,535 patients, a lower hazard for PCCRC (n = 178) was observed for higher APCs as compared to APCs of <.25 (reference): .25 to <.40: hazard ratio (HR), .35; 95% confidence interval (CI), .22-.56; .40 to <.50: HR, .31; 95% CI, .20-.49; .50 to <.70: HR, .20; 95% CI, .11-.36; and ≥.70: HR, .19; 95% CI, .09-.37. When examining endoscopists with an ADR of at least 25%, an APC of <.50 was associated with a significantly higher hazard than an APC of ≥.50 (HR, 1.65; 95% CI, 1.06-2.56). A large proportion of endoscopists-one-fifth (32 of 152; 21.1%)-had an ADR of ≥25% but an APC of <.50. CONCLUSIONS: Our novel data demonstrating lower PCCRC risk in examinations performed by endoscopists with higher APCs suggest that APC could be a useful quality measure. Quality improvement programs may identify important deficiencies in endoscopist detection performance by measuring APC for endoscopists with an ADR of ≥25%.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Anderson JC, Rex DK, Mackenzie TA, et al. Endoscopist adenomas-per-colonoscopy detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2023. PMID: 37993057. doi:10.1016/j.gie.2023.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。